EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Utility of MEF2B immunohistochemistry in distinguishing follicular lymphoma and marginal zone lymphoma in diagnostically challenging cases

Joanna C Dalland, Oluwayomi S Oyedeji, David S Viswanatha, Cody J Artymiuk, Matthew T Howard, Rebecca L King

Journal of Hematopathology · 01.07.2026 · 19 (1)

DOI: 10.1007/s12308-026-00717-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hematopathology, online erschienen am 01.07.2026. Verfasst von Joanna C Dalland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Dalland.jo…. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, MEF2 Transcription Factors, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, FollicularLymphoma, B-Cell, Marginal ZoneMEF2 Transcription FactorsBiomarkers, TumorHumansImmunohistochemistryDiagnosis, DifferentialFemaleMale

Stichwörter der Autor:innen

Follicular lymphomaGerminal centerMEF2BMarginal zone differentiationMarginal zone lymphomaMyocyte enhancer binding factor B

Substanzen

MEF2B protein, humanMEF2 Transcription FactorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Dalland.joanna@mayo.edu.
  • Great Lake Pathologists SC (GLP), West Allis, WI, USA.
  • Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Zitieren

APA

Dalland, J. C., Oyedeji, O. S., Viswanatha, D. S., Artymiuk, C. J., Howard, M. T., & King, R. L. (2026). Utility of MEF2B immunohistochemistry in distinguishing follicular lymphoma and marginal zone lymphoma in diagnostically challenging cases. Journal of Hematopathology, 19(1). https://doi.org/10.1007/s12308-026-00717-2

Vancouver

Dalland JC, Oyedeji OS, Viswanatha DS, Artymiuk CJ, Howard MT, King RL. Utility of MEF2B immunohistochemistry in distinguishing follicular lymphoma and marginal zone lymphoma in diagnostically challenging cases. Journal of Hematopathology. 2026;19(1). doi:10.1007/s12308-026-00717-2

BibTeX
@article{Dalland2026,
  author = {Dalland, Joanna C and Oyedeji, Oluwayomi S and Viswanatha, David S and Artymiuk, Cody J and Howard, Matthew T and King, Rebecca L},
  title = {Utility of MEF2B immunohistochemistry in distinguishing follicular lymphoma and marginal zone lymphoma in diagnostically challenging cases},
  journal = {Journal of Hematopathology},
  year = {2026},
  volume = {19},
  number = {1},
  doi = {10.1007/s12308-026-00717-2}
}
Kostenlos starten →